Financials
- Market Capitalization 818.63 M
- Employee 294
- Founded N/A
- CEO Sheldon Koenig
- Website www.esperion.com
- Headquarter Delaware, United States
- FIGI BBG004KB3S72
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2565 | EVO Evotec SE - American Depositary Shares each representing 1/2 of | 2.43 USD | -12.90% | -14.44% | -13.83% | -43.09% | 864.01 M USD | ||
| 2576 | AMPH Amphastar Pharmaceuticals, Inc. - Common Stock | 19.29 USD | +3.04% | -3.84% | -4.08% | -20.88% | 850.55 M USD | ||
| 2703 | IRWD Ironwood Pharmaceuticals, Inc. - Class A Common Stock | 4.21 USD | -5.82% | -6.03% | +11.67% | +468.92% | 693.02 M USD | ||
| 2896 | TLRY Tilray Brands, Inc. - Common Stock | 4.46 USD | +0.90% | +0.45% | -12.20% | +565.67% | 519.81 M USD |
Frequently asked questions about Esperion Therapeutics, Inc. - Common Stock
What is the Esperion Therapeutics, Inc. - Common Stock stock price today?
The current price of Esperion Therapeutics, Inc. - Common Stock (ESPR) is 3.18. Over the past 24 hours, the stock has changed by -0.31%. Follow the ESPR chart for real-time price dynamics.
What is the stock ticker of Esperion Therapeutics, Inc. - Common Stock?
Esperion Therapeutics, Inc. - Common Stock trades under the ticker ESPR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Esperion Therapeutics, Inc. - Common Stock stock going up?
ESPR has changed by +0.63% over the last week, +0.63% over the last month, and +169.49% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Esperion Therapeutics, Inc. - Common Stock net income for the last quarter?
Esperion Therapeutics, Inc. - Common Stock reported net income of -25.2 M for the last quarter. The previous quarter showed 61.83 M, which means net income changed by -140.75%.
How many employees does Esperion Therapeutics, Inc. - Common Stock have?
As of the latest available data, Esperion Therapeutics, Inc. - Common Stock has 294 employees. Workforce size can provide additional context about the company's scale and operations.
What is Esperion Therapeutics, Inc. - Common Stock EBITDA?
Esperion Therapeutics, Inc. - Common Stock EBITDA is -5.96 M, and its EBITDA margin is -7.45%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Esperion Therapeutics, Inc. - Common Stock stock?
You can buy Esperion Therapeutics, Inc. - Common Stock (ESPR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Esperion Therapeutics, Inc. - Common Stock stock?
Investing in Esperion Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ESPR chart and related analysis on metatrader.com as part of your research.